| Identification | Back Directory | [Name]
Palbociclib-012 | [CAS]
2206135-30-8 | [Synonyms]
Palbociclib-012
di-tert-butyl 4,4'-(((8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidine-2,6-diyl)bis(azanediyl))bis(pyridine-6,3-diyl))bis(piperazine-1-carboxylate)
di-tert-Butyl 4,4'-(6,6'-((8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidine-2,6-diyl)bis(azanediyl))bis(pyridine-6,3-diyl))bis(piperazine-1-carboxylate)
Palbociclib impurity 15/di-tert-butyl 4,4'-(((8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidine-2,6-diyl)bis(azanediyl))bis(pyridine-6,3-diyl))bis(piperazine-1-carboxylate)
"di-tert-Butyl 4,4-(6,6-((8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidine-2,6-diyl)bis(azanediyl))bis(pyridine-6,3-diyl))bis(piperazine-1-carboxylate)"Q: What is
"di-tert-Butyl 4,4-(6,6-((8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidine-2,6-diyl)bis(azanediyl))bis(pyridine-6,3-diyl))bis(piperazine-1-carboxylate)" Q: What is the CAS Number of
"di-tert-Butyl 4,4-(6,6-((8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidine-2,6-diyl)bis(azanediyl))bis(pyridine-6,3-diyl))bis(piperazine-1-carboxylate)" | [Molecular Formula]
C41H55N11O5 | [MOL File]
2206135-30-8.mol | [Molecular Weight]
781.96 |
| Chemical Properties | Back Directory | [Boiling point ]
918.6±75.0 °C(Predicted) | [density ]
1.302±0.06 g/cm3(Predicted) | [pka]
6.28±0.10(Predicted) | [InChIKey]
ZXAOMPKUBCILTQ-UHFFFAOYSA-N | [SMILES]
O=C1C(=C(C2=CN=C(N=C2N1C1CCCC1)NC1N=CC(N2CCN(CC2)C(=O)OC(C)(C)C)=CC=1)C)NC1N=CC(N2CCN(CC2)C(=O)OC(C)(C)C)=CC=1 |
| Hazard Information | Back Directory | [Uses]
di-tert-Butyl 4,4''-(6,6''-((8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidine-2,6-diyl)bis(azanediyl))bis(pyridine-6,3-diyl))bis(piperazine-1-carboxylate) is an impurity of Palbociclib (P139900) an experimental drug for the treatment of breast cancer being developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6. |
|
|